<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: generic manufacturers</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Fearing abuse, US blocks generic OxyContin (Update)</title>
   	 <description>U.S. health regulators will require generic versions of the best-selling painkiller OxyContin to include recent formulation changes designed to make the pill harder to abuse.</description>
     <link>http://medicalxpress.com/news/2013-04-abuse-fda-blocks-oxycontin.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 16 Apr 2013 17:47:37 EST</pubDate>
	 <guid isPermaLink="false">news285353249</guid>
	 
</item>
<item>
     <title>Misuse of drug patenting could cost the health system billions</title>
   	 <description>(Medical Xpress)—Companies may be misusing the drug patenting system in order to gain control over high-cost drugs in Australia, research from the Melbourne Law School has found.</description>
     <link>http://medicalxpress.com/news/2013-04-misuse-drug-patenting-health-billions.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 10 Apr 2013 09:21:59 EST</pubDate>
	 <guid isPermaLink="false">news284804511</guid>
	 
</item>
<item>
     <title>Court: Can generic makers be sued for drug flaws?</title>
   	 <description>(AP)—The Supreme Court will decide whether generic drug manufacturers can be held responsible in state courts for possible design defects that are in the brand-name medicine they are copying.</description>
     <link>http://medicalxpress.com/news/2012-11-court-makers-sued-drug-flaws.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 30 Nov 2012 15:58:26 EST</pubDate>
	 <guid isPermaLink="false">news273513479</guid>
	 
</item>
<item>
     <title>India licenses generic copy of patented Bayer drug</title>
   	 <description>(AP) --  India effectively ended Bayer's monopoly on a patented cancer drug Monday, licensing a much cheaper generic under a unique law aimed at keeping costs affordable.</description>
     <link>http://medicalxpress.com/news/2012-03-india-patented-bayer-drug.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 12 Mar 2012 17:30:01 EST</pubDate>
	 <guid isPermaLink="false">news250791132</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/indialicense.jpg" width="90" height="90" />
</item>
<item>
     <title>India's global pharmacy role threatened by EU pact</title>
   	 <description>(AP) --  Efforts by India and the European Union to strengthen trade are threatening India's ability to deliver lifesaving medicines to the world's poorest, analysts say as the two sides push through protracted negotiations on a free-trade pact.</description>
     <link>http://medicalxpress.com/news/2012-02-india-global-pharmacy-role-threatened.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 10 Feb 2012 05:30:02 EST</pubDate>
	 <guid isPermaLink="false">news248074058</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/indiasglobal.jpg" width="90" height="90" />
</item>
<item>
     <title>More AIDS patients may get cheaper drugs</title>
   	 <description>(AP) --  Gilead Sciences Inc. will allow some of its AIDS drugs to be made by generic manufacturers, potentially increasing their availability in poor countries, particularly in Africa, officials said Tuesday.</description>
     <link>http://medicalxpress.com/news/2011-07-aids-patients-cheaper-drugs.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Tue, 12 Jul 2011 08:24:31 EST</pubDate>
	 <guid isPermaLink="false">news229677419</guid>
	 
</item>


</channel>
</rss>
